EP1449911A1 - Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen - Google Patents
Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen Download PDFInfo
- Publication number
- EP1449911A1 EP1449911A1 EP03003176A EP03003176A EP1449911A1 EP 1449911 A1 EP1449911 A1 EP 1449911A1 EP 03003176 A EP03003176 A EP 03003176A EP 03003176 A EP03003176 A EP 03003176A EP 1449911 A1 EP1449911 A1 EP 1449911A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- matrix
- active ingredients
- preparations according
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CIO[C@](C(*)C1O)OC(CO)[C@]1O[C@@](C1N)OC(*)[C@@](*)C1O Chemical compound CIO[C@](C(*)C1O)OC(CO)[C@]1O[C@@](C1N)OC(*)[C@@](*)C1O 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
- D06M23/12—Processes in which the treating agent is incorporated in microcapsules
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/001—Softening compositions
- C11D3/0015—Softening compositions liquid
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/18—Hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/373—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicones
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3749—Polyolefins; Halogenated polyolefins; Natural or synthetic rubber; Polyarylolefins or halogenated polyarylolefins
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/02—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with hydrocarbons
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/227—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of hydrocarbons, or reaction products thereof, e.g. afterhalogenated or sulfochlorinated
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/643—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicon in the main chain
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2200/00—Functionality of the treatment composition and/or properties imparted to the textile material
- D06M2200/20—Treatment influencing the crease behaviour, the wrinkle resistance, the crease recovery or the ironing ease
Definitions
- the invention is in the field of laundry treatment agents and relates to new preparations with microencapsulated active ingredients that improve ironing behavior, a process for the treatment of textiles and the use of special microencapsulated Active ingredients for laundry equipment.
- the object of the present invention was therefore to provide new aqueous preparations with which textiles can be finished in such a way that easy ironing is possible ( " easy ironing effect") without the disadvantages of the prior art being associated therewith are.
- the active ingredients should be easy to incorporate and the resulting aqueous preparations should be stable on storage. Another wish was still to use such active substances that have additional positive effects in connection with the textile finish.
- the invention relates to aqueous preparations, for example fabric softener, Liquid detergent or laundry detergent, with microencapsulated active ingredients, which are characterized by the fact that the active substances are substances which Improve the ironing behavior of textiles.
- the preparations according to the invention contain the known active ingredients now included used in microencapsulated form.
- the microcapsules additional dyes, for example transparent preparations are possible, which Active substances in the form of clearly visible, for example blue or red colored spherical Forms contain what may be desired for aesthetic reasons, because it is Consumers immediately notice the presence of active auxiliary substances.
- the microencapsulated Active substances are drawn onto the fibers; when ironed, the capsules become mechanical broken open and then release the active ingredient spontaneously.
- microencapsulated active ingredients are used in which the shell consists entirely or at least predominantly of chitosan. Chitosan also owns the tendency to pull on fibers. Since it has nourishing and antibacterial properties, is the desired additional with the use of chitosan microcapsules Benefits achieved.
- the main active ingredients that improve the ironing behavior of textiles are silicone compounds, Paraffin waxes, polyolefin waxes and their mixtures in question.
- Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones as well as amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl modified silicone compounds, the can be both liquid and resinous at room temperature.
- simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates.
- paraffin waxes saturated hydrocarbons are sufficient To understand carbon chain length that only at temperatures above soften or melt at 50, preferably above 60 ° C.
- the paraffin waxes can also be partially oxidized, i.e. have free carboxyl groups.
- polyolefin waxes are polyethylene waxes, polypropylene waxes and to understand their mixtures. Suitable representatives are those who are only at Soften temperatures above 50, preferably above 60 ° C or melt. Polyolefin waxes, such as e.g. the Adalin® product K (Cognis Deutschland GmbH & Co. KG)
- Both the silicone compounds and the waxes can be in the form of aqueous emulsions or dispersions are used, the active substance content in the range of 1 can be up to 25% by weight. Small amounts of suitable ones can be used as further constituents Emulsifiers can also be used.
- microcapsule is understood by the person skilled in the art to mean spherical aggregates with a diameter in the range from approximately 0.0001 to approximately 5 mm, which contain at least one solid or liquid core which is enclosed by at least one continuous shell. More precisely, it involves finely dispersed liquid or solid phases coated with film-forming polymers, in the production of which the polymers precipitate on the material to be encased after emulsification and coacervation or interfacial polymerization. According to another method, melted waxes are taken up in a matrix ( " microsponge"), which as microparticles can additionally be coated with film-forming polymers.
- the microscopic capsules, also called nanocapsules can be dried like powder.
- multinuclear aggregates also called microspheres
- Single or multi-core microcapsules can also be enclosed by an additional second, third, etc. shell.
- the shell can consist of natural, semi-synthetic or synthetic materials.
- wrapping materials are, for example, gum arabic, agar agar, agarose, maltodextrins, alginic acid or its salts, for example sodium or calcium alginate, fats and fatty acids, cetyl alcohol, collagen, chitosan, lecithins, gelatin, albumin, shellac, polysaccharides, such as starch or Dextran, polypeptides, protein hydrolyzates, sucrose and waxes.
- Semi-synthetic casing materials include chemically modified celluloses, in particular cellulose esters and ethers, for example cellulose acetate, ethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose and carboxymethyl cellulose, and starch derivatives, in particular starch ethers and esters.
- Synthetic covering materials are, for example, polymers such as polyacrylates, polyamides, polyvinyl alcohol or polyvinyl pyrrolidone.
- microcapsules of the prior art are the following commercial products (the shell material is given in brackets) : Hallcrest microcapsules (gelatin, gum arabic), Coletica Thalaspheres (maritime collagen), Lipotec millicapsules (alginic acid, agar agar), Induchem Unispheres (lactose , microcrystalline cellulose, hydroxypropylmethyl cellulose); Unicerin C30 (lactose, microcrystalline cellulose, hydroxypropylmethylcellulose), Kobo Glycospheres (modified starch, fatty acid esters, phospholipids), Softspheres (modified agar agar) and Kuhs Probiol Nanospheres (phospholipids) as well as Primaspheres and Primasponges (Chitosan, Alysol phosphates ) and Alginate ,
- such substances are preferably considered as gel formers drawn, which show the property in aqueous solution at temperatures above of 40 ° C to form gels.
- Typical examples are heteropolysaccharides and proteins.
- Agaroses are preferably used as thermogelating heteropolysaccharides in question, which together in the form of the agar agar to be obtained from red algae with up to 30% by weight of non-gel-forming agaropectins.
- the main constituent of the agaroses are linear polysaccharides from D-galactose and 3,6-anhydro-L-galactose, which are linked alternately ⁇ -1,3- and ⁇ -1,4-glycosidically.
- the heteropolysaccharides preferably have a molecular weight in the range from 110,000 to 160,000 and are both colorless and tasteless.
- Pectins, xanthans (also xanthan gum) and mixtures thereof can be used. Those types which are still in 1% by weight aqueous solution are also preferred Form gels that do not melt below 80 ° C and are already above of 40 ° C solidify again. From the group of thermogeling proteins the different types of gelatin are mentioned as examples.
- Chitosans are biopolymers and belong to the group of hydrocolloids. From a chemical point of view, these are partially deacetylated chitins of different molecular weights that contain the following - idealized - monomer unit: In contrast to most hydrocolloids, which are negatively charged in the range of biological pH values, chitosans are cationic biopolymers under these conditions. The positively charged chitosans can interact with oppositely charged surfaces and are therefore used in cosmetic hair and body care products as well as pharmaceuticals Preparations used. The production of chitosans is based on chitin, preferably the shell remains of crustaceans, which are available in large quantities as cheap raw materials.
- the chitin is used in a process that was first developed by Hackmann et al. has been described, usually first deproteinized by adding bases, demineralized by adding mineral acids and finally deacetylated by adding strong bases, it being possible for the molecular weights to be distributed over a broad spectrum.
- Those types are preferably used which have an average molecular weight of 10,000 to 500,000 or 800,000 to 1,200,000 Daltons and / or a Brookfield viscosity (1% by weight in glycolic acid) below 5000 mPas, a degree of deacetylation in the range have from 80 to 88% and an ash content of less than 0.3% by weight.
- the chitosans are generally used in the form of their salts, preferably as glycolates.
- the matrix can optionally be dispersed in an oil phase before the membrane is formed.
- Suitable oils for this purpose are, for example, Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C 6 -C 22 fatty acids with linear C 6 -C 22 fatty alcohols, esters of branched C 6 -C 13 carboxylic acids with linear C 6 -C 22 -fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, Myristylisostearat, myristyl, Myristylbehenat, Myristylerucat, cetyl myristate, cetyl palmitate, cetyl stearate, Cetylisostearat, cetyl oleate, cetyl behenate, Cetylerucat, Stearylmyristat, stearyl palmitate, stearyl stearate, Steary
- esters of linear C 6 -C 22 fatty acids with branched alcohols in particular 2-ethylhexanol
- esters of hydroxycarboxylic acids with linear or branched C 6 -C 22 fatty alcohols in particular dioctyl malates
- esters of linear and / or branched fatty acids are also suitable polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on C 6 -C 10 fatty acids, liquid mono- / di- / triglyceride mixtures based on C 6 -C 18 fatty acids, esters of C 6 -C 22 fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, especially benzoic acid, esters of C 2 -C 12 dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atom
- Finsolv® TN linear or branched, symmetrical or unsymmetrical dialkyl ethers with 6 to 22 carbon atoms per alkyl group, ring opening products of epoxidized fatty acid esters with polyols, silicone oils and / or aliphatic or naphthenic Hydrocarbons, such as squalane, squalene or dialkylcyclohexanes.
- the anionic polymers have the task of forming membranes with the chitosans. Salts of alginic acid are preferably suitable for this purpose.
- Alginic acid is a mixture of carboxyl-containing polysaccharides with the following idealized monomer unit:
- the average molecular weight of the alginic acids or alginates is in the range from 150,000 to 250,000.
- Salts of alginic acid are to be understood to mean both their complete and their partial neutralization products, in particular the alkali metal salts and preferably the sodium alginate ( “ algin”) and the ammonium and alkaline earth metal salts.
- Mixed alginates such as sodium / magnesium or sodium / calcium alginates, are particularly preferred.
- anionic chitosan derivatives such as carboxylation and especially succinylation products, are also suitable for this purpose.
- poly (meth) acrylates with average molecular weights in the range from 5,000 to 50,000 daltons and the various carboxymethyl celluloses are also suitable.
- anionic polymers anionic surfactants or low molecular weight inorganic salts, such as, for example, pyrophosphates, can also be used for the formation of the envelope membrane.
- the microcapsules are usually prepared in a 1 to 10, preferably 2 to 5 % By weight aqueous solution of the gel former, preferably the agar, and heated this under reflux. At boiling point, preferably at 80 to 100 ° C, a second added aqueous solution containing the chitosan in amounts of 0.1 to 2, preferably 0.25 up to 0.5% by weight and the active compounds in amounts of 0.1 to 25 and in particular 0.25 to 10 % By weight; this mixture is called the matrix.
- the loading of the microcapsules with active ingredients can therefore also 0.1 to 25 wt .-% based on the capsule weight be.
- water-insoluble ones can also be used at this time to adjust the viscosity Components, for example inorganic pigments, are added, where they are usually added in the form of aqueous or aqueous / alcoholic dispersions.
- inorganic pigments for example inorganic pigments
- the Matrix of gelling agent, chitosan and active ingredients the matrix can optionally in an oil phase be dispersed very finely under strong shear in order to be encapsulated in the following to produce the smallest possible particles.
- the resulting aqueous Preparations generally have a microcapsule content in the range from 1 to 10% by weight on.
- the solution of the polymers is further Contains ingredients, such as emulsifiers or preservatives.
- emulsifiers or preservatives After filtration microcapsules are obtained which preferably have an average diameter in the range of have about 1 mm. It is advisable to sift the capsules to get one if possible ensure even size distribution.
- the microcapsules obtained in this way can manufacturing-related frames have any shape, but they are preferably approximate spherical.
- the anionic polymers can also be used to prepare the Insert the matrix and encapsulate it with the chitosans.
- an O / W emulsion is first prepared, which in addition to the oil body, water and Active ingredients contain an effective amount of emulsifier. This is used to manufacture the matrix Preparation with vigorous stirring with an appropriate amount of an aqueous anion polymer solution added.
- Polysaccharides in particular Xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and Hydroxyethylcellulose, higher molecular weight polyethylene glycol mono- and diesters of fatty acids, Polyacrylates, polyacrylamides and the like can still be supported. Finally the microcapsules are removed from the aqueous phase, for example by decanting, Filter or centrifuge separated.
- the preparations can usually contain microencapsulated active ingredients in amounts of 0.1 up to 10, preferably 1 to 8 and in particular 2 to 5% by weight, based on the composition.
- the agents are aqueous solutions that are only which contain microcapsules and, if appropriate, suitable thickeners. This is for example in the case of laundry treatment agents of the ironing aid type which the laundry is treated immediately before ironing.
- the preparations can be used all still anionic, nonionic, cationic and / or amphoteric or zwitterionic Contain surfactants.
- anionic surfactants are soaps, alkylbenzenesulfonates, alkanesulfonates, Olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, Alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, hydroxy mixed ether sulfates, Monoglyceride (ether) sulfates, fatty acid amide (ether) sulfates, mono- and dialkyl sulfosuccinates, Mono- and dialkyl sulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, N-
- anionic surfactants polyglycol ether chains contain, these can be a conventional, but preferably a narrow homolog distribution exhibit.
- Alkylbenzenesulfonates, alkylsulfates, soaps, Alkane sulfonates, olefin sulfonates, methyl ester sulfonates and mixtures thereof are used.
- Preferred alkylbenzenesulfonates follow the formula (I) R 1 -Ph-SO 3 X in which R 1 is a branched but preferably linear alkyl radical having 10 to 18 carbon atoms, Ph is a phenyl radical and X is an alkali and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium.
- R 1 is a branched but preferably linear alkyl radical having 10 to 18 carbon atoms
- Ph is a phenyl radical
- X is an alkali and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium.
- dodecylbenzenesulfonates, tetradecylbenzenesulfonates, hexadecylbenzenesulfonates and their technical mixtures in the form of the sodium salts are particularly suitable
- Alkyl and / or alkenyl sulfates which are also often referred to as fatty alcohol sulfates, are to be understood as meaning the sulfation products of primary and / or secondary alcohols, which preferably follow the formula (II) R 2 O-SO 3 X in which R 2 represents a linear or branched, aliphatic alkyl and / or alkenyl radical having 6 to 22, preferably 12 to 18 carbon atoms and X represents an alkali metal and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium.
- alkyl sulfates which can be used in the context of the invention are the sulfation products of capron alcohol, caprylic alcohol, capric alcohol, 2-ethylhexyl alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, aryl selenyl alcohol, elaidyl alcohol, Behenyl alcohol and erucyl alcohol and their technical mixtures, which are obtained by high pressure hydrogenation of technical methyl ester fractions or aldehydes from Roelen's oxosynthesis.
- the sulfation products can preferably be used in the form of their alkali metal salts and in particular their sodium salts.
- Alkyl sulfates based on C 16/18 tallow fatty alcohols or vegetable fatty alcohols of comparable C chain distribution in the form of their sodium salts are particularly preferred.
- these are oxo alcohols, as are obtainable, for example, by converting carbon monoxide and hydrogen to alpha-containing olefins using the shop process.
- Such alcohol mixtures are commercially available under the trade names Dobanol® or Neodol®. Suitable alcohol mixtures are Dobanol 91®, 23®, 25®, 45®.
- oxo alcohols such as those obtained by the classic Enichema or Condea oxo process by adding carbon monoxide and hydrogen to olefins.
- These alcohol mixtures are a mixture of strongly branched alcohols.
- Such alcohol mixtures are commercially available under the trade name Lial®.
- Suitable alcohol mixtures are Lial 91®, 111®, 123®, 125®, 145®.
- Soaps are to be understood as meaning fatty acid salts of the formula (III) R 3 CO-OX in which R 3 CO represents a linear or branched, saturated or unsaturated acyl radical having 6 to 22 and preferably 12 to 18 carbon atoms and again X represents alkali and / or alkaline earth metal, ammonium, alkylammonium or alkanolammonium.
- Typical examples are the sodium, potassium, magnesium, ammonium and triethanolammonium salts of caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmoleic acid, stearic acid, isostearic acid, oleic acid, elaoleic acid, petoleic acid, linoleic acid, petoleic acid, linoleic acid, petoleic acid, linoleic acid, linoleic acid, Linolenic acid, elaeostearic acid, arachic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures.
- coconut or palm kernel fatty acid is preferably used in the form of its sodium or potassium salts.
- nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, Fatty acid polyglycol ester, fatty acid amide polyglycol ether, fatty amine polyglycol ether, alkoxylated triglycerides, mixed ethers or mixed formals, alk (en) yl oligoglycosides, Fatty acid-N-alkylglucamides, protein hydrolyzates (especially vegetable products based on wheat), Polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
- nonionic surfactants contain polyglycol ether chains, these can be a conventional, but preferably have a narrow homolog distribution. Preferably become fatty alcohol polyglycol ethers, alkoxylated fatty acid lower alkyl esters or alkyl oligoglucosides used.
- the preferred fatty alcohol polyglycol ethers follow the formula (IV) R 4 O (CH 2 CHR 5 O) n1 H in which R 4 represents a linear or branched alkyl and / or alkenyl radical having 6 to 22, preferably 12 to 18 carbon atoms, R 5 represents hydrogen or methyl and n1 represents numbers from 1 to 20.
- Typical examples are the addition products of an average of 1 to 20 and preferably 5 to 10 moles of ethylene and / or propylene oxide with capron alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, oleyl alcohol, isostyl alcohol , Petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures. Addition products of 3, 5 or 7 moles of ethylene oxide onto technical coconut oil alcohols are particularly preferred.
- Suitable alkoxylated fatty acid lower alkyl esters are surfactants of the formula (V) R 6 CO- (OCH 2 CHR 7 ) n2 OR 8 in which R 6 CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R 7 is hydrogen or methyl, R 8 is a linear or branched alkyl radical having 1 to 4 carbon atoms and n2 is a number from 1 to 20 stands.
- Typical examples are the formal insert products of on average 1 to 20 and preferably 5 to 10 moles of ethylene and / or propylene oxide in the methyl, ethyl, propyl, isopropyl, butyl and tert-butyl esters of caproic acid, caprylic acid, 2 -Ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and technical grade and erucas.
- the products are usually prepared by inserting the alkylene oxides into the carbonyl ester bond in the presence of special catalysts, such as, for example, calcined hydrotalcite. Reaction products of an average of 5 to 10 moles of ethylene oxide into the ester linkage of technical coconut fatty acid methyl esters are particularly preferred.
- Alkyl and alkenyl oligoglycosides which are also preferred nonionic surfactants, usually follow the formula (VI), R 9 O- [G] p in which R 8 is an alkyl and / or alkenyl radical having 4 to 22 carbon atoms, G is a sugar radical having 5 or 6 carbon atoms and p is a number from 1 to 10. They can be obtained according to the relevant procedures in preparative organic chemistry.
- the alkyl and / or alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
- the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligo glucosides.
- Alkyl and / or alkenyl oligoglycosides with an average degree of oligomerization p of 1.1 to 3.0 are preferably used. From an application point of view, preference is given to those alkyl and / or alkenyl oligoglycosides whose degree of oligomerization is less than 1.7 and is in particular between 1.2 and 1.4.
- the alkyl or alkenyl radical R 9 can be derived from primary alcohols having 4 to 11, preferably 8 to 10, carbon atoms.
- Typical examples are butanol, capronic alcohol, caprylic alcohol, capric alcohol and undecyl alcohol and their technical mixtures, such as are obtained, for example, in the hydrogenation of technical fatty acid methyl esters or in the course of the hydrogenation of aldehydes from Roelen's oxosynthesis.
- the alkyl or alkenyl radical R 9 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14, carbon atoms. Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol and their technical mixtures, which can be obtained as described above. Alkyl oligoglucosides based on hardened C 12/14 coconut alcohol with a DP of 1 to 3 are preferred.
- cationic surfactants are, in particular, tetraalkylammonium compounds, such as, for example, dimethyldistearylammonium chloride or hydroxyethyl hydroxycetyldimmonium chloride (Dehyquart E), or else esterquats, which are typically a constituent of finishing agents.
- tetraalkylammonium compounds such as, for example, dimethyldistearylammonium chloride or hydroxyethyl hydroxycetyldimmonium chloride (Dehyquart E), or else esterquats, which are typically a constituent of finishing agents.
- R 10 CO for an acyl radical with 6 to 22 carbon atoms
- R 11 and R 12 independently of one another for hydrogen or R 10 CO
- R 11 for an alkyl radical with 1 to 4 carbon atoms or a (CH 2 CH 2 O) m4 H- Group
- m1, m2 and m3 in total for 0 or numbers from 1 to 12
- m4 for numbers from 1 to 12 and Y for halide
- ester quats that can be used in the context of the invention are products based on caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, isostearic acid, stearic acid, oleic acid, elaidic acid, arachic acid, behenic acid and erucic acid and their technical mixtures, such as they occur, for example, in the pressure splitting of natural fats and oils.
- Technical C 12/18 coconut fatty acids and in particular partially hardened C 16/18 tallow or palm fatty acids as well as C 16/18 fatty acid cuts rich in elaidic acid are preferably used.
- the fatty acids and the triethanolamine can be used in a molar ratio of 1.1: 1 to 3: 1 to produce the quaternized esters.
- an application ratio of 1.2: 1 to 2.2: 1, preferably 1.5: 1 to 1.9: 1 has proven to be particularly advantageous.
- the preferred esterquats are technical mixtures of mono-, di- and triesters with an average degree of esterification of 1.5 to 1.9 and are derived from technical C 16/18 - tallow or palm fatty acid (iodine number 0 to 40).
- quaternized fatty acid triethanolamine ester salts of the formula (VII) have proven to be particularly advantageous in which R 10 CO for an acyl radical having 16 to 18 carbon atoms, R 11 for R 10 CO, R 12 for hydrogen, R 13 for a methyl group, m1 , m2 and m3 stands for 0 and Y for methyl sulfate.
- quaternized ester salts of fatty acids with diethanolalkylamines of the formula (VIII) may also be used as ester quats.
- R 14 CO for an acyl radical with 6 to 22 carbon atoms
- R 15 for hydrogen or R 14 CO
- R 16 and R 17 independently of one another for alkyl radicals with 1 to 4 carbon atoms
- m5 and m6 in total for 0 or numbers from 1 to 12
- Y again represents halide, alkyl sulfate or alkyl phosphate.
- ester salts of fatty acids with 1,2-dihydroxypropyl dialkylamines of the formula (IX) should be mentioned as a further group of suitable ester quats, in which R 18 CO for an acyl radical with 6 to 22 carbon atoms, R 19 for hydrogen or R 18 CO, R 20 , R 21 and R 22 independently of one another for alkyl radicals with 1 to 4 carbon atoms, m7 and m8 in total for 0 or numbers from 1 to 12 and X again represents halide, alkyl sulfate or alkyl phosphate.
- suitable esterquats are substances in which the ester bond is replaced by an amide bond and which preferably follow the formula (X) based on diethylenetriamine, in which R 23 CO represents an acyl radical having 6 to 22 carbon atoms, R 24 represents hydrogen or R 23 CO, R 25 and R 26 independently of one another represent alkyl radicals having 1 to 4 carbon atoms and Y again represents halide, alkyl sulfate or alkyl phosphate.
- Such amide ester quats are available on the market, for example, under the Incroquat® (Croda) brand.
- alkyl betaines examples include alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
- alkyl betaines are the carboxyalkylation products of secondary and in particular tertiary amines which follow the formula (XI) in which R 27 for alkyl and / or alkenyl radicals with 6 to 22 carbon atoms, R 28 for hydrogen or alkyl radicals with 1 to 4 carbon atoms, R 29 for alkyl radicals with 1 to 4 carbon atoms, q1 for numbers from 1 to 6 and Z for a Alkali and / or alkaline earth metal or ammonium.
- Typical examples are the carboxymethylation products of hexylmethylamine, hexyldimethylamine, octyldimethylamine, decyldimethylamine, dodecylmethylamine, dodecyldimethylamine, Dodecylethylmethylamin, C 12/14 -Kokosalkyldimethylamin, myristyldimethylamine, cetyldimethylamine, stearyldimethylamine, stearyl, oleyl, C 16/18 tallow alkyl dimethyl amine and technical mixtures thereof.
- Carboxyalkylation products of amidoamines which follow the formula (XII) are also suitable, in which R 30 CO for an aliphatic acyl radical with 6 to 22 carbon atoms and 0 or 1 to 3 double bonds, R 31 for hydrogen or alkyl radicals with 1 to 4 carbon atoms, R 32 for alkyl radicals with 1 to 4 carbon atoms, q2 for numbers from 1 to 6, q3 for numbers from 1 to 3 and Z again represents an alkali and / or alkaline earth metal or ammonium.
- Typical examples are reaction products of fatty acids with 6 to 22 carbon atoms, namely caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, gadoleic acid and arachic acid, arachic acid and their technical mixtures, with N, N-dimethylaminoethylamine, N, N-dimethylaminopropylamine, N, N-diethylaminoethylamine and N, N-diethylaminopropylamine, which are condensed with sodium chloroacetate.
- condensation product of C 8/18 coconut fatty acid N, N-dimethylaminopropylamide with sodium chloroacetate is preferred.
- Imidazolinium betaines are also suitable. These substances are also known substances which can be obtained, for example, by cyclizing condensation of 1 or 2 moles of fatty acid with polyhydric amines such as, for example, aminoethyl ethanolamine (AEEA) or diethylene triamine.
- AEEA aminoethyl ethanolamine
- the corresponding carboxyalkylation products are mixtures of different open-chain betaines.
- Typical examples are condensation products of the above-mentioned fatty acids with AEEA, preferably imidazolines based on lauric acid or again C 12/14 coconut fatty acid, which are subsequently betainized with sodium chloroacetate.
- the preparations impart such a high viscosity that the microcapsules remain stably dispersed, i.e. do not sediment over time.
- the term increased viscosity is therefore a to understand such rheology which stabilizes the microcapsules in the aqueous (surfactant) phase ensures.
- Such viscosities are usually (determined according to Brookfield, RVT viscometer, 20 ° C, spindle 1, 10 rpm) above 100 and preferably above 500 mPas, preferably in the range from 200 to 2,000 and in particular 500 to 1,000 mPas.
- Suitable thickeners are all the substances that make up the formulations give correspondingly high viscosity.
- polymeric Compounds are preferably polymeric Compounds, since these are able to form a three-dimensional in the aqueous preparations To build a network in which the microcapsules are stabilized.
- Typical examples are Aerosil types (hydrophilic silicas), polysaccharides, especially xanthan gum, Guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and Hydroxypropyl cellulose, also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, (e.g.
- Bentonites such as Bentone® Gel VS-5PC (Rheox) proven to be a mixture of cyclopentasiloxane, disteardimonium hectorite and propylene carbonate.
- the proportion of these thickeners in the aqueous preparations can be 0.1 to 5, preferably 0.5 to 3 and in particular 1 to 2% by weight.
- Two other objects of the present invention relate to a method for improvement the ironing behavior of textiles, in which the fibers, yarns or textile fabrics are used with microencapsulated active ingredients selected from the group which is formed by silicone compounds, paraffin waxes and polyolefin waxes as well the use of microencapsulated silicone compounds, paraffin waxes and / or Polyolefin waxes for the production of laundry treatment agents.
- microencapsulated active ingredients selected from the group which is formed by silicone compounds, paraffin waxes and polyolefin waxes as well the use of microencapsulated silicone compounds, paraffin waxes and / or Polyolefin waxes for the production of laundry treatment agents.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Textile Engineering (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
- (b1) aus Gelbildnern, anionischen Polymeren und Wirkstoffen eine Matrix zubereitet,
- (b2) gegebenenfalls die Matrix in einer Ölphase dispergiert,
- (b3) die dispergierte Matrix mit wässrigen Chitosanlösungen behandelt und gegebenenfalls dabei die Ölphase entfernt.
- (c1) wässrige Wirkstoffzubereitungen mit Ölkörpern in Gegenwart von Emulgatoren zu O/W-Emulsionen verarbeitet,
- (c2) die so erhaltenen Emulsionen mit wässrigen Lösungen anionischer Polymere behandelt,
- (c3) die so erhaltene Matrix mit wässrigen Chitosanlösungen in Kontakt bringt und
- (c4) die so erhaltenen Verkapselungsprodukte von der wässrigen Phase abtrennt.
- Anlagerungsprodukte von 2 bis 30 Mol Ethylenoxid und/ oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen, an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe sowie Alkylamine mit 8 bis 22 Kohlenstoffatomen im Alkylrest;
- Alkyl- und/oder Alkenyloligoglykoside mit 8 bis 22 Kohlenstoffatomen im Alk(en)ylrest und deren ethoxylierte Analoga;
- Anlagerungsprodukte von 1 bis 15 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;
- Anlagerungsprodukte von 15 bis 60 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;
- Partialester von Glycerin und/oder Sorbitan mit ungesättigten, linearen oder gesättigten, verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;
- Partialester von Polyglycerin (durchschnittlicher Eigenkondensationsgrad 2 bis 8), Polyethylenglycol (Molekulargewicht 400 bis 5000), Trimethylolpropan, Pentaerythrit, Zuckeralkoholen (z.B. Sorbit), Alkylglucosiden (z.B. Methylglucosid, Butylglucosid, Laurylglucosid) sowie Polyglucosiden (z.B. Cellulose) mit gesättigten und/oder ungesättigten, linearen oder verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;
- Mischester aus Pentaerythrit, Fettsäuren, Citronensäure und Fettalkohol und/oder Mischester von Fettsäuren mit 6 bis 22 Kohlenstoffatomen, Methylglucose und Polyolen, vorzugsweise Glycerin oder Polyglycerin.
- Mono-, Di- und Trialkylphosphate sowie Mono-, Di- und/oder Tri-PEGalkylphosphate und deren Salze;
- Wollwachsalkohole;
- Polysiloxan-Polyalkyl-Polyether-Copolymere bzw. entsprechende Derivate;
- Block-Copolymere z.B. Polyethylenglycol-30 Dipolyhydroxystearate;
- Polymeremulgatoren, z.B. Pemulen-Typen (TR-1,TR-2) von Goodrich;
- Polyalkylenglycole sowie
- Glycerincarbonat.
Zusammensetzung wässriger Zubereitungen | ||||
Zusammensetzung | 1 | 2 | 3 | 4 |
C12/18-Kokosalkohol+5EO Dehydol® LT5 | 25,0 | 25,0 | - | - |
C12/18-Kokosalkohol+7EO Dehydol® LT7 | 10,0 | - | - | - |
Mischether ) Dehypon® KE 3447 | - | 10,0 | - | - |
Dipalmoylmethylethoxymonium Methosulfate Dehyquart® AU 54 | - | - | 25,0 | - |
Carbopol | 0,49 | 0,49 | 0,49 | |
Farbstoff | 0,01 | 0,01 | 0,01 | |
Mikrokapseln Bsp. 1 | 1,0 | - | - | 1,0 |
Mikrokapseln Bsp. 2 | - | 1,0 | - | - |
Mikrokapseln Bsp. 3 | - | - | 1,0 | - |
Wasser | ad 100 |
Claims (14)
- Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen, dadurch gekennzeichnet, dass die Wirkstoffe Substanzen darstellen, welche das Bügelverhalten von Textilien verbessern.
- Zubereitungen nach Anspruch 1, dadurch gekennzeichnet, dass es sich um Wäscheweichspülmittel handelt.
- Zubereitungen nach Anspruch 1, dadurch gekennzeichnet, dass es sich um Flüssigwaschmittel handelt.
- Zubereitungen nach Anspruch 1, dadurch gekennzeichnet, dass es sich um Wäschenachbehandlungsmittel handelt.
- Zubereitungen nach mindestens einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass die Wirkstoffe ausgewählt sind aus der Gruppe, die gebildet wird von Silikonverbindungen, Paraffinwachsen und Polyolefinwachsen.
- Zubereitungen nach Anspruch 5, dadurch gekennzeichnet, dass die Silikonverbindungen ausgewählt sind aus der Gruppe, die gebildet wird von Dimethylpolysiloxanen, Methylphenylpolysiloxanen, cyclischen Silikonen sowie amino-, fettsäure-, alkohol-, polyether-, epoxy-, fluor-, glykosid- und/oder alkylmodifizierten Silikonen.
- Zubereitungen nach Anspruch 5, dadurch gekennzeichnet, dass die Polyolefinwachse Polyethylen- und/oder Polypropylenwachse darstellen.
- Zubereitungen nach mindestens einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass die Wirkstoffe in einer wässrigen Emulsion oder Dispersion vorliegen.
- Zubereitungen nach mindestens einem der Ansprüche 1 bis 8, dadurch gekennzeichnet, dass sie Mikrokapseln mit mittleren Durchmessern im Bereich von 0,0001 bis 5 mm, bestehend aus einer Hüllmembran und einer die Wirkstoffe enthaltenden Matrix enthalten, welche dadurch erhältlich sind, dass man(a1) aus Gelbildnem, Chitosanen und Wirkstoffen eine Matrix zubereitet,(a2) gegebenenfalls die Matrix in einer Ölphase dispergiert,(a3) die dispergierte Matrix mit wässrigen Lösungen anionischer Polymere behandelt und gegebenenfalls dabei die Ölphase entfernt.(b1) aus Gelbildnern, anionischen Polymeren und Wirkstoffen eine Matrix zubereitet,(b2) gegebenenfalls die Matrix in einer Ölphase dispergiert,(b3) die dispergierte Matrix mit wässrigen Chitosanlösungen behandelt und gegebenenfalls dabei die Ölphase entfernt.(c1) wässrige Wirkstoffzubereitungen mit Ölkörpern in Gegenwart von Emulgatoren zu O/W-Emulsionen verarbeitet,(c2) die so erhaltenen Emulsionen mit wässrigen Lösungen anionischer Polymere behandelt,(c3) die so erhaltene Matrix mit wässrigen Chitosanlösungen in Kontakt bringt und(c4) die so erhaltenen Verkapselungsprodukte von der wässrigen Phase abtrennt.
- Zubereitungen nach mindestens einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, dass sie die mikroverkapselten Wirkstoffe in Mengen von 0,1 bis 10 Gew.-% - bezogen auf die Mittel - enthalten.
- Zubereitungen nach mindestens einem der Ansprüche 1 bis 10, dadurch gekennzeichnet, dass sie weiterhin anionische, nichtionische, kationische und/oder amphotere bzw. zwitterionische Tenside enthalten.
- Zubereitungen nach mindestens einem der Ansprüche 1 bis 11, dadurch gekennzeichnet, dass sie weiterhin Verdickungsmittel enthalten.
- Verfahren zur Verbesserung des Bügelverhaltens von Textilien, bei dem man die Fasern, Garne oder textilen Flächengebilde mit mikroverkapselten Wirkstoffen ausrüstet, die ausgewählt sind aus der Gruppe, die gebildet wird von Silikonverbindungen, Paraffinwachsen und Polyolefinwachsen.
- Verwendung von mikroverkapselten Silikonverbindungen, Paraffinwachsen und/oder Polyolefinwachsen zur Herstellung von Wäschebehandlungsmitteln.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03003176A EP1449911B1 (de) | 2003-02-18 | 2003-02-18 | Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen |
ES03003176T ES2286341T3 (es) | 2003-02-18 | 2003-02-18 | Preparaciones acuosas con productos activvos microencasulados. |
AT03003176T ATE364681T1 (de) | 2003-02-18 | 2003-02-18 | Wässrige zubereitungen mit mikroverkapselten wirkstoffen |
DE50307461T DE50307461D1 (de) | 2003-02-18 | 2003-02-18 | Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03003176A EP1449911B1 (de) | 2003-02-18 | 2003-02-18 | Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1449911A1 true EP1449911A1 (de) | 2004-08-25 |
EP1449911B1 EP1449911B1 (de) | 2007-06-13 |
Family
ID=32731520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03003176A Expired - Lifetime EP1449911B1 (de) | 2003-02-18 | 2003-02-18 | Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1449911B1 (de) |
AT (1) | ATE364681T1 (de) |
DE (1) | DE50307461D1 (de) |
ES (1) | ES2286341T3 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2882765A1 (fr) * | 2005-03-07 | 2006-09-08 | Rowenta Werke Gmbh Ges Mit Bes | Appareil pour repasser ou defroisser le linge comportant un reservoir d'additif |
CN103806285A (zh) * | 2013-10-11 | 2014-05-21 | 天津市中科健新材料技术有限公司 | 一种用于卫生制品的恒温无纺布制备方法 |
EP2688996B1 (de) | 2011-03-22 | 2015-05-06 | Henkel AG&Co. KGAA | Flüssiges waschmittel mit kapseln |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3632296A (en) * | 1968-04-12 | 1972-01-04 | Cluett Peabody & Co Inc | Application of reactants and/or catalysts to textile fabrics in microencapsulated form |
DE2632318A1 (de) * | 1975-07-21 | 1977-02-17 | Procter & Gamble | Zur verwendung in fluessigen textilkonditioniermitteln geeignete kapseln |
WO2001001927A1 (de) * | 1999-07-02 | 2001-01-11 | Primacare S.A. | Mikrokapseln - i |
WO2001025385A1 (en) * | 1999-10-05 | 2001-04-12 | Ciba Specialty Chemicals Holding Inc. | Fabric softener compositions |
WO2001062376A1 (de) * | 2000-02-23 | 2001-08-30 | Henkel Kommanditgesellschaft Auf Aktien | Mikro- und/oder nanokapseln |
EP1201818A1 (de) * | 2000-10-27 | 2002-05-02 | The Procter & Gamble Company | Verfahren zum Bügeln von Textilien und Nachfüllkartuschen für Bügeleisen |
WO2002064725A1 (en) * | 2001-02-12 | 2002-08-22 | The Procter & Gamble Company | Delivery system having encapsulated porous carrier loaded with additives |
-
2003
- 2003-02-18 EP EP03003176A patent/EP1449911B1/de not_active Expired - Lifetime
- 2003-02-18 ES ES03003176T patent/ES2286341T3/es not_active Expired - Lifetime
- 2003-02-18 DE DE50307461T patent/DE50307461D1/de not_active Expired - Lifetime
- 2003-02-18 AT AT03003176T patent/ATE364681T1/de not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3632296A (en) * | 1968-04-12 | 1972-01-04 | Cluett Peabody & Co Inc | Application of reactants and/or catalysts to textile fabrics in microencapsulated form |
DE2632318A1 (de) * | 1975-07-21 | 1977-02-17 | Procter & Gamble | Zur verwendung in fluessigen textilkonditioniermitteln geeignete kapseln |
WO2001001927A1 (de) * | 1999-07-02 | 2001-01-11 | Primacare S.A. | Mikrokapseln - i |
WO2001025385A1 (en) * | 1999-10-05 | 2001-04-12 | Ciba Specialty Chemicals Holding Inc. | Fabric softener compositions |
WO2001062376A1 (de) * | 2000-02-23 | 2001-08-30 | Henkel Kommanditgesellschaft Auf Aktien | Mikro- und/oder nanokapseln |
EP1201818A1 (de) * | 2000-10-27 | 2002-05-02 | The Procter & Gamble Company | Verfahren zum Bügeln von Textilien und Nachfüllkartuschen für Bügeleisen |
WO2002064725A1 (en) * | 2001-02-12 | 2002-08-22 | The Procter & Gamble Company | Delivery system having encapsulated porous carrier loaded with additives |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2882765A1 (fr) * | 2005-03-07 | 2006-09-08 | Rowenta Werke Gmbh Ges Mit Bes | Appareil pour repasser ou defroisser le linge comportant un reservoir d'additif |
WO2006095226A1 (fr) * | 2005-03-07 | 2006-09-14 | Rowenta Werke Gmbh | Appareil pour repasser ou defroisser le linge comportant un reservoir d'additif |
US7661212B2 (en) | 2005-03-07 | 2010-02-16 | Rowenta Werke Gmbh | Appliance for ironing or steaming linen, comprising a container for additive |
CN101133203B (zh) * | 2005-03-07 | 2011-05-04 | 罗文塔公司 | 用于熨或者整平衣物的包括添加剂容器的设备 |
EP2688996B1 (de) | 2011-03-22 | 2015-05-06 | Henkel AG&Co. KGAA | Flüssiges waschmittel mit kapseln |
CN103806285A (zh) * | 2013-10-11 | 2014-05-21 | 天津市中科健新材料技术有限公司 | 一种用于卫生制品的恒温无纺布制备方法 |
CN103806285B (zh) * | 2013-10-11 | 2016-05-11 | 天津市中科健新材料技术有限公司 | 一种用于卫生制品的恒温无纺布制备方法 |
Also Published As
Publication number | Publication date |
---|---|
DE50307461D1 (de) | 2007-07-26 |
EP1449911B1 (de) | 2007-06-13 |
ATE364681T1 (de) | 2007-07-15 |
ES2286341T3 (es) | 2007-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1715834B1 (de) | Mikroemulsionen | |
EP1359247B1 (de) | Mit Mikrokapseln ausgerüstete Fasern und textile Flächengebilde | |
EP2694014A2 (de) | Ein haarpflegemittel | |
EP1449912B1 (de) | Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen | |
EP1359212B1 (de) | Tensidzubereitungen enthaltend mikroverkapselte Wirkstoffe | |
EP3038590A1 (de) | Kosmetische mittel | |
EP1358872B1 (de) | Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel | |
WO2002076604A1 (de) | Mikrokapseln (viii) | |
EP1449911B1 (de) | Wässrige Zubereitungen mit mikroverkapselten Wirkstoffen | |
EP1359213B1 (de) | Wässrige Tensidzubereitungen | |
EP1358876B1 (de) | Mikrokapseln mit Anti-Aknewirkstoffen | |
EP1243321A1 (de) | Mikrokapseln(IX) | |
DE10213031A1 (de) | Verwendung von Extrakten des Olivenbaumes in Wasch-, Spül- und Reinigungsmitteln | |
EP1378564A1 (de) | Portionierte flüssige Wasch- und Reinigungsmittelzubereitungen | |
EP1167618A1 (de) | Textilhilfsmittel | |
EP1430947A1 (de) | Mikropartikel mit flüssigkristallinen Kompartimenten | |
WO2004009095A1 (de) | Verwendung von benzoylperoxid und glyzyrrhetinsäure enthaltende zusammensetzunden zur aknebehandlung | |
EP1243322A1 (de) | Mikrokapseln(X) | |
DE10307389A1 (de) | Anti-Aknemittel | |
DE10329685A1 (de) | Mikrokapseln (XXV) | |
DE102004006405A1 (de) | Drucklabile Mikrokapseln | |
DE10307388A1 (de) | Glyzyrrhetinsäureester | |
EP1657299A1 (de) | Mikrokapseln | |
EP1382342A1 (de) | Verwendung von Salicylsäure und Glyzyrrhetinsäure enhaltende Zusammensetzungen zur Aknebehandlung | |
DE10307387A1 (de) | (w-1)-Hydroxyfestsäureester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030218 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: COGNIS IP MANAGEMENT GMBH |
|
17Q | First examination report despatched |
Effective date: 20050513 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REF | Corresponds to: |
Ref document number: 50307461 Country of ref document: DE Date of ref document: 20070726 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070913 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20070905 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2286341 Country of ref document: ES Kind code of ref document: T3 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070913 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070914 |
|
26N | No opposition filed |
Effective date: 20080314 |
|
BERE | Be: lapsed |
Owner name: COGNIS IP MANAGEMENT G.M.B.H. Effective date: 20080228 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080228 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080229 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080228 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071214 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220222 Year of fee payment: 20 Ref country code: DE Payment date: 20220225 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20220221 Year of fee payment: 20 Ref country code: FR Payment date: 20220224 Year of fee payment: 20 Ref country code: ES Payment date: 20220311 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 50307461 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20230217 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20230427 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20230217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20230219 |